Evidence map›Paper›PMID 41472249›Full record

ArticleViruses2025

Development of a Novel Virus-Like Particle-Based Vaccine Against PRV-1 Suitable for DIVA Strategies.

Claudia Galleguillos-Becerra, Matias Cardenas, Yesseny Vásquez-Martínez, Francisca Tapia, Zulema Yañez, Tomas Cancino, Iván Valdés, Marcelo Cortez-San Martín

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Claudia Galleguillos-BecerraFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Matias CardenasFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.ORCID 0000-0001-8247-3669
Yesseny Vásquez-MartínezFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.ORCID 0000-0002-4184-9815
Francisca TapiaFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Zulema YañezFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.
Tomas CancinoLaboratorios Veterquimica SA, Santiago 9200000, Chile.
Iván ValdésLaboratorios Veterquimica SA, Santiago 9200000, Chile.
Marcelo Cortez-San MartínFacultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170022, Chile.

Funding

ANID National Doctoral Scholarship 21192264Corfo 18ITE1-102979Fondef IT 23I0044
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fish DiseasesHerpesvirus 1, SuidOrthoreovirusReoviridae InfectionsVaccines, Virus-Like ParticleViral VaccinesAnimalsAntibodies, ViralAquacultureOncorhynchus mykissSalmo salarVaccine DevelopmentViral LoadAntibodies, ViralVaccines, Virus-Like ParticleViral Vaccinescmyc epitopePiscine orthoreovirusVLP vaccine

Identifiers

PMID41472249
PMCPMC12737571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.